These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 32791184)
1. Clinical significance of reactive oxidative metabolites in patients with heart failure with reduced left ventricular ejection fraction. Nishihara T; Tokitsu T; Sueta D; Oike F; Takae M; Fujisue K; Usuku H; Ito M; Kanazawa H; Araki S; Arima Y; Takashio S; Nakamura T; Sakamoto K; Suzuki S; Kaikita K; Yamamoto E; Tsujita K J Card Fail; 2021 Jan; 27(1):57-66. PubMed ID: 32791184 [TBL] [Abstract][Full Text] [Related]
2. Impact of Reactive Oxidative Metabolites Among New Categories of Nonischemic Heart Failure. Nishihara T; Yamamoto E; Sueta D; Fujisue K; Usuku H; Oike F; Takae M; Tabata N; Ito M; Yamanaga K; Kanazawa H; Arima Y; Araki S; Takashio S; Nakamura T; Suzuki S; Sakamoto K; Izumiya Y; Kaikita K; Tsujita K J Am Heart Assoc; 2021 Apr; 10(7):e016765. PubMed ID: 33733816 [TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen metabolites are closely associated with the diagnosis and prognosis of coronary artery disease. Hirata Y; Yamamoto E; Tokitsu T; Kusaka H; Fujisue K; Kurokawa H; Sugamura K; Maeda H; Tsujita K; Kaikita K; Hokimoto S; Sugiyama S; Ogawa H J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25630910 [TBL] [Abstract][Full Text] [Related]
4. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes. Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553 [TBL] [Abstract][Full Text] [Related]
5. The clinical significance of plasma neopterin in heart failure with preserved left ventricular ejection fraction. Yamamoto E; Hirata Y; Tokitsu T; Kusaka H; Tabata N; Tsujita K; Yamamuro M; Kaikita K; Watanabe H; Hokimoto S; Maruyama T; Ogawa H ESC Heart Fail; 2016 Mar; 3(1):53-59. PubMed ID: 27774267 [TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics of heart failure with recovered ejection fraction]. Luo Y; Chai K; Cheng YL; Zhu WR; Li YY; Wang H; Yang JF Zhonghua Xin Xue Guan Bing Za Zhi; 2021 Apr; 49(4):333-339. PubMed ID: 33874682 [No Abstract] [Full Text] [Related]
7. Phenotyping Heart Failure According to the Longitudinal Ejection Fraction Change: Myocardial Strain, Predictors, and Outcomes. Park JJ; Mebazaa A; Hwang IC; Park JB; Park JH; Cho GY J Am Heart Assoc; 2020 Jun; 9(12):e015009. PubMed ID: 32519555 [TBL] [Abstract][Full Text] [Related]
8. The Pivotal Role of a Novel Biomarker of Reactive Oxygen Species in Chronic Kidney Disease. Hirata Y; Yamamoto E; Tokitsu T; Fujisue K; Kurokawa H; Sugamura K; Sakamoto K; Tsujita K; Tanaka T; Kaikita K; Hokimoto S; Sugiyama S; Ogawa H Medicine (Baltimore); 2015 Jun; 94(25):e1040. PubMed ID: 26107676 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Prognostic Usefulness of Serum Insulin-Like Growth Factor-Binding Protein 7 in Patients With Heart Failure and Preserved Versus Reduced Left Ventricular Ejection Fraction. Hage C; Bjerre M; Frystyk J; Gu HF; Brismar K; Donal E; Daubert JC; Linde C; Lund LH Am J Cardiol; 2018 Jun; 121(12):1558-1566. PubMed ID: 29622288 [TBL] [Abstract][Full Text] [Related]
10. The prognostic value of brain natriuretic peptide in patients with heart failure and left ventricular ejection fraction higher than 60%: a sub-analysis of the J-MELODIC study. Kitada S; Kikuchi S; Tsujino T; Masuyama T; Ohte N; ESC Heart Fail; 2018 Feb; 5(1):36-45. PubMed ID: 28941144 [TBL] [Abstract][Full Text] [Related]
11. Combination of ST2 and B-type natriuretic peptide in diabetic patients with acute heart failure: relation with ventricular stiffness and outcome. Ruocco G; Evangelista I; Franci B; Lucani B; Martini S; Nuti R; Palazzuoli A J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):81-90. PubMed ID: 30540645 [TBL] [Abstract][Full Text] [Related]
12. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction. Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958 [TBL] [Abstract][Full Text] [Related]
13. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002 [TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of Brachial-Ankle Pulse Wave Velocity in Patients With Heart Failure With Reduced Left Ventricular Ejection Fraction. Takae M; Yamamoto E; Tokitsu T; Oike F; Nishihara T; Fujisue K; Sueta D; Usuku H; Motozato K; Ito M; Kanazawa H; Araki S; Nakamura T; Arima Y; Takashio S; Suzuki S; Sakamoto K; Soejima H; Yamabe H; Kaikita K; Tsujita K Am J Hypertens; 2019 Jun; 32(7):657-667. PubMed ID: 31090886 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of cardiac I-123-metaiodobenzylguanidine imaging in patients with reduced, mid-range, and preserved left ventricular ejection fraction admitted for acute decompensated heart failure: a prospective study in Osaka Prefectural Acute Heart Failure Registry (OPAR). Seo M; Yamada T; Tamaki S; Watanabe T; Morita T; Furukawa Y; Kawasaki M; Kikuchi A; Kawai T; Abe M; Nakamura J; Yamamoto K; Kayama K; Kawahira M; Tanabe K; Kimura T; Ueda K; Sakamoto D; Sakata Y; Fukunami M Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):58-66. PubMed ID: 32091079 [TBL] [Abstract][Full Text] [Related]
17. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction. Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801 [TBL] [Abstract][Full Text] [Related]
18. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction. Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225 [TBL] [Abstract][Full Text] [Related]
19. Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 Study. Kasahara S; Sakata Y; Nochioka K; Yamauchi T; Onose T; Tsuji K; Abe R; Oikawa T; Sato M; Aoyanagi H; Miura M; Shiroto T; Takahashi J; Miyata S; Shimokawa H; Heart Vessels; 2018 Sep; 33(9):997-1007. PubMed ID: 29569034 [TBL] [Abstract][Full Text] [Related]
20. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction. Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]